BioXcel Therapeutics, Inc.
METHODS FOR TREATING AGITATION USING DEXMEDETOMIDINE HYDROCHLORIDE

Abstract:

The present disclosure relates to the treatment of agitation or signs of agitation in certain human subjects, including subjects with a neurodegenerative, neuropsychiatric or opioid withdrawal disorder, by administering dexmedetomidine hydrochloride by the intravenous route.